DAFNA Capital Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-111,501
| Closed | -$1.19M | – | 90 |
|
|
2021
Q3 | $1.19M | Sell |
111,501
-1,801
| -2% | -$19.2K | 0.32% | 67 |
|
|
2021
Q2 | $1.02M | Hold |
113,302
| – | – | 0.21% | 71 |
|
|
2021
Q1 | $1.2M | Buy |
113,302
+100
| +0.1% | +$1.06K | 0.28% | 69 |
|
|
2020
Q4 | $1.43M | Sell |
113,202
-35,058
| -24% | -$442K | 0.42% | 49 |
|
|
2020
Q3 | $1.3M | Buy |
+148,260
| New | +$1.3M | 0.42% | 48 |
|
|
2016
Q4 | – | Sell |
-3,750
| Closed | -$122K | – | 74 |
|
|
2016
Q3 | $122K | Hold |
3,750
| – | – | 0.09% | 69 |
|
|
2016
Q2 | $69K | Hold |
3,750
| – | – | 0.05% | 86 |
|
|
2016
Q1 | $63K | Hold |
3,750
| – | – | 0.05% | 89 |
|
|
2015
Q4 | $116K | Hold |
3,750
| – | – | 0.1% | 72 |
|
|
2015
Q3 | $195K | Hold |
3,750
| – | – | 0.19% | 72 |
|
|
2015
Q2 | $227K | Buy |
+3,750
| New | +$227K | 0.19% | 63 |
|